Sort
46,585 grants matching “heart failure”
TCF7L2 Insoforms in Canonical Wnt Signaling During Cardiac Hpertrophy & Failure
$491,618Faqian Li · University Of Texas Hlth Science Center · R01 · FY2022 · HL
Effect of Statins and Modifiable Factors on Stroke Outcome in Atrial Fibrillation
$491,585Elaine Hylek · Boston Medical Center · R01 · FY2012 · NS
Development of an intravascular circulatory support device for high-risk for percutaneous coronary intervention and cardiogenic shock
$491,583Jeffrey Larose · Rt Cardiac Systems, Inc. · R43 · FY2020 · HL
Impact of Emerging Health Insurance Designs on Diabetes Complications
$491,543James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2016 · DK
Impact of Emerging Health Insurance Designs on Diabetes Complications
$491,543James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2017 · DK
Mitophagy and Cardiac Myocyte Protein Aggregation
$491,458Abhinav Diwan · Washington University · R01 · FY2025 · HL
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia
$491,435Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2012 · HL
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia
$491,435Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2016 · HL
Blood Pressure in Dialysis Patients
$491,373Philip George Zager · University Of New Mexico · R01 · FY2011 · DK
MicroRNA as mediators of angiogenesis & ischemic myocardial repair
$491,362Meifeng Xu · University Of Cincinnati · R01 · FY2015 · HL
Depot calcineurin inhibitors to prevent graft rejection
$491,344Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2009 · AI
BLOOD PRESSURE CONTROL IN HYPERTENSIVE SMOKERS
$491,242Mark W. Vander Weg · University Of Iowa · R01 · FY2008 · HL
Energetic State and Metabolic Remodeling in Cardiac Hypertrophy and Failure
$491,209Qinglin Yang · Lsu Health Sciences Center · R01 · FY2022 · HL
Comparison of exercise responses in four ESRD treatments
$491,144University Of California San Francisco · R01 · FY2004 · NR
Multi-level analysis of iron metabolism and treatment of chronic kidney disease
$491,109Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · DK
Molecular Mechanisms and Treatment of Primary Amyloid AL Cardiomyopathy
$491,063Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2014 · HL
Cell type-Specific Therapeutic Targeting of canonical WNT Pathway in Arrhythmogenic Cardiomyopathy
$491,003Ali J. Marian · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · HL
Targeting resitin and RELM-beta to treat pulmonary hypertension
$490,962Roger A Johns · Johns Hopkins University · P50 · FY2012 · HL
CHANGES IN HEALTH: SOCIO-ECONOMIC STATUS AND PATHWAYS
$490,884University Of London Inst Of Neurology · R37 · FY2001 · AG
Metabolic Regulation of Cardiac E-C Coupling
$490,848University Of California Los Angeles · R01 · FY2005 · HL
TCF7L2 isoforms in canonical Wnt signaling during cardiac hypertrophy and failure
$490,825Faqian Li · University Of Minnesota · R01 · FY2021 · HL
IFN-gamma, smooth muscle cells and graft arteriosclerosis
$490,824George Tellides · Yale University · P01 · FY2007 · HL
Novel functions of E-C coupling structural protein junctophilin-2 in the heart
$490,689Long-Sheng Song · University Of Iowa · R01 · FY2016 · HL
Thrombospondin 4 regulates adaptive ER stress response
$490,661Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · HL
Molecular Biomedical Imaging Laboratory (NIBIB)
$490,660David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2016 · EB